SESPF yields 1.33% · JNJ yields 2.13%● Live data
📍 SESPF pulled ahead of the other in Year 1
Combined, SESPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SESPF + JNJ for your $10,000?
SeSa S.p.A., together with its subsidiaries, distributes value-added information technology (IT) products and solutions in Italy and internationally. The company operates Value- Added Distribution, Software and System Integration, and Business Services segments. The company provides enterprise software solutions, which includes solutions for storage, data management, and data analysis; data centre solutions include cloud server and storage solutions for data processing; device and digital workspace; networking and collaboration, and digital green solutions. It offers technological solutions, digital services, and business applications for the SME and enterprise sector; security solutions; ERP and industry solutions; digital engineering; and digital platform solutions. The company is headquartered in Empoli, Italy. SeSa S.p.A. is a subsidiary of ITH SpA.
Full SESPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.